Cargando…

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) quality of care guidelines are consensus-based. The effectiveness of the recommendations is unknown. OBJECTIVE: To determine whether clinic-level quality of care affects clinical and patient-reported outcomes. METHODS: This nationwide observational cohort study in...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Anna H, Manouchehrinia, Ali, Glaser, Anna, Ciccarelli, Olga, Butzkueven, Helmut, Hillert, Jan, McKay, Kyla Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413789/ https://www.ncbi.nlm.nih.gov/pubmed/37392018 http://dx.doi.org/10.1177/13524585231181578

Ejemplares similares

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
por: He, Anna, et al.
Publicado: (2023)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
por: He, Anna, et al.
Publicado: (2023)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022)

Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
por: Song, Jie, et al.
Publicado: (2018)

Income in Multiple Sclerosis Patients with Different Disease Phenotypes
por: Kavaliunas, Andrius, et al.
Publicado: (2017)

The importance of collecting structured clinical information on multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Depression and multiple sclerosis: A bidirectional Mendelian randomisation study
por: Binzer, Stefanie, et al.
Publicado: (2021)

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
por: McKay, Kyla A., et al.
Publicado: (2021)

Association between brain volume and disability over time in multiple sclerosis
por: Moridi, Thomas, et al.
Publicado: (2022)

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
por: McKay, Kyla A., et al.
Publicado: (2021)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
por: Manouchehrinia, Ali, et al.
Publicado: (2018)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
por: Hillert, Jan, et al.
Publicado: (2021)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019)

Importance of early treatment decisions on future income of multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2020)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
por: Boles, Graysen Steele, et al.
Publicado: (2023)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Association of plasma levels of Protein S with disease severity in multiple sclerosis
por: Ma, Gerry ZM, et al.
Publicado: (2015)

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe
por: Nicholas, Richard, et al.
Publicado: (2023)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
por: Forsberg, Lars, et al.
Publicado: (2023)

Season of birth is associated with multiple sclerosis and disease severity
por: Stridh, P, et al.
Publicado: (2021)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
por: Delcoigne, Bénédicte, et al.
Publicado: (2020)

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
por: Gresle, Melissa M., et al.
Publicado: (2011)

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2022)

Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022)

Smoking and multiple sclerosis susceptibility
por: Hedström, Anna Karin, et al.
Publicado: (2013)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
por: Zondra Revendova, Kamila, et al.
Publicado: (2022)

Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study
por: Manouchehrinia, Ali, et al.
Publicado: (2015)

Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
por: Kavaliunas, Andrius, et al.
Publicado: (2022)

Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients
por: Kavaliunas, Andrius, et al.
Publicado: (2015)

Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
por: Geissbühler, Yvonne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_thbksrrlucpo7131nhmi3a9f8g